SciTransfer
Organization

UNIVERSIDAD COMPLUTENSE DE MADRID

Spain's largest university with deep expertise in biomedical nanomaterials, quantum physics, AI, and epidemiology across 113 H2020 projects.

University research groupmultidisciplinaryES
H2020 projects
113
As coordinator
38
Total EC funding
€48.3M
Unique partners
912
What they do

Their core work

UCM is Spain's largest public university and a major European research institution with deep strengths in biomedical sciences, materials science, and fundamental physics. Their H2020 portfolio reveals a university that bridges fundamental research — quantum systems, attosecond chemistry, nanomagnetism — with applied biomedical work in drug delivery, bone disease treatment, and epidemiology. They are also active in digital technologies (AI, machine learning, gamified learning platforms) and increasingly in societal challenges such as gender equality, citizen science, and sustainable development. With 113 EU projects and nearly EUR 48.3M in funding, UCM operates as a high-volume, multidisciplinary research partner across virtually every scientific domain.

Core expertise

What they specialise in

Biomedical nanomaterials and drug deliveryprimary
8 projects

Projects like VERDI (mesoporous nanosystems for bone diseases, EUR 2.5M as coordinator), MOZART (mesoporous matrices for drug release), MAGNAMED (magnetic nanostructures for medical applications), and 3D NEONET demonstrate sustained depth in nanoscale therapeutics.

Fundamental and quantum physicsprimary
5 projects

GAPS (spectral gaps in quantum systems, EUR 1.46M ERC grant as coordinator) and CLIMAGNET (Earth's magnetic field effects on climate) show strong theoretical physics capability.

10 projects

Projects span from early game-based learning (RAGE, BEACONING) to recent AI and machine learning applications, plus cybersecurity forensics (RAMSES); recent keywords confirm a shift toward AI/ML.

Inflammation, epidemiology and public healthsecondary
7 projects

Multiple MSCA and RIA projects focus on inflammation biomarkers, obesity, ageing, HIV therapeutics (HIVACAR), and dry eye disease (EDEN, coordinated by UCM).

Attosecond chemistry and ultrafast scienceemerging
2 projects

Recent-period keywords highlight attosecond chemistry as a new research direction, consistent with Europe's growing investment in ultrafast laser science.

4 projects

STARS4ALL (dark skies awareness), RISEWISE (women with disabilities), and recent keywords around citizen science, gender, and sustainable development show growing societal research.

Evolution & trajectory

How they've shifted over time

Early focus
Quantum physics and digital learning
Recent focus
Biomedical AI and societal challenges

In the first half of their H2020 participation (2015-2018), UCM focused heavily on fundamental physics (quantum Hamiltonians, magnetism), digital learning platforms (gaming ecosystems, educational tools), and astronomy. The second half (2019-2022) shows a marked pivot toward applied biomedical research (nanomaterials, inflammation, additive manufacturing for health), artificial intelligence and machine learning, and societal challenges like gender equality and citizen science. This trajectory reflects a university moving from curiosity-driven science toward translational research with clearer societal and industrial impact.

UCM is increasingly combining data science (AI/ML) with biomedical and materials research, making them a strong partner for projects requiring computational approaches to health and nanomedicine.

Collaboration profile

How they like to work

Role: active_partnerReach: Global69 countries collaborated

UCM operates predominantly as an active partner (74 projects as participant vs. 38 as coordinator), but their 34% coordination rate is high for a university of this size, showing genuine leadership capacity. With 912 unique consortium partners across 69 countries, they are a network hub rather than a repeat-partner organization — they bring connectivity to virtually any European consortium. Their involvement in MSCA-RISE and MSCA-IF programs indicates strong commitment to researcher mobility and international knowledge exchange.

UCM has collaborated with 912 unique partners across 69 countries, making it one of the most connected universities in H2020. Their network spans all of Europe with significant reach into Latin America, North Africa, and Asia through MSCA mobility programs.

Why partner with them

What sets them apart

UCM stands out among Spanish universities for the sheer breadth and volume of its EU research — 113 H2020 projects across 16 different programme pillars is exceptional even by large university standards. Their combination of deep fundamental science (ERC-level quantum physics) with applied nanomedicine and growing AI capability makes them a versatile consortium partner who can contribute across multiple work packages. For consortium builders, UCM offers a rare combination: a historically prestigious institution with genuine research depth, massive international connectivity, and willingness to both lead and support.

Notable projects

Highlights from their portfolio

  • VERDI
    Largest single grant (EUR 2.5M) as coordinator, focused on mesoporous nanosystems for bone diseases — represents UCM's core strength in biomedical nanomaterials.
  • GAPS
    EUR 1.46M ERC-level grant as coordinator on quantum spin systems — demonstrates world-class theoretical physics capability.
  • RAGE
    Major digital innovation project (EUR 534K) on applied gaming ecosystems with broad industry partnership, showing UCM's reach beyond traditional academic research.
Cross-sector capabilities
healthdigitalmanufacturingfood
Analysis note: Profile based on 30 of 113 projects shown in detail; the remaining 83 projects are reflected in aggregate statistics. The true depth in any single domain may be stronger than what the sample reveals. UCM's extreme breadth (16 H2020 pillars) makes it genuinely multidisciplinary rather than having a single dominant specialization.